The role played by the extraneuronal system in the disposition of noradrenaline and adrenaline in vessels
- 1 February 1977
- journal article
- research article
- Published by Springer Science and Business Media LLC in Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie
- Vol. 296 (3), 279-287
- https://doi.org/10.1007/bf00498694
Abstract
The role played by extraneuronal sites in the disposition of noradrenaline and adrenaline was studied in the saphenous vein and in the mesenteric artery of the dog, taking as parameters the influence of blockade of these sites on the sensitivity to and on the time for half-relaxation (t 50) (both in oil and in Krebs solution) of these agonists. Preliminary experiments have shown that the t 50 values are not significantly changed by the changes in the height of the contraction provided the contraction is caused by the same concentration of the agonist. The results obtained permit us to conclude that in both vessels the removal of amines depends on the concentrations used. In low (0.023 and 0.23 μM) or in moderately high (2.3 μM) concentrations, adrenaline is removed preferentially by extraneuronal sites, whereas noradrenaline “preferred” neuronal sites. The selectivity of adrenaline for extraneuronal sites was present for such low concentrations that a possible physiological role of these sites in the inactivation of circulating adrenaline must be considered. The results obtained by studying the relaxation in oil or in Krebs solution and by using cortexone (60 μM) or U-0521 (dihydroxy-2-methyl propiophenone; 0.1 mM) support the view that, at least in the vein, adrenaline may accumulate in extraneuronal cells and diffuse back into the biophase during the relaxation, thereby slowing the latter. Both in the veins and in the arteries noradrenaline was inactivated more rapidly than adrenaline. The difference in the rate of inactivation of these amines, already observed in controls (when all inactivation pathways are operative) became more marked when both neuronal and extraneuronal sites were blocked. The existence of an important pathway not blocked by cocaine + cortexone + iproniazid which may preferentially inactivate noradrenaline cannot be ruled out.This publication has 24 references indexed in Scilit:
- Further study of the adrenoceptors of the saphenous vein of the dog: Influence of factors which interfere with the concentrations of agonists at the receptor levelEuropean Journal of Pharmacology, 1975
- Response of the Rabbit Coronary Arteries to Autonomic AgentsJournal of Vascular Research, 1974
- The slopes of cumulative and non-cumulative dose-response curves for nonadrenaline and isoprenalineEuropean Journal of Pharmacology, 1972
- The effects of cocaine and denervation on the sensitivity to noradrenaline, its uptake and the termination of its action in isolated venous tissueNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1971
- The role of Uptake2 in the extraneuronal metabolism of catecholamines in the isolated rat heartBritish Journal of Pharmacology, 1969
- Adrenergic receptors in the veins of the dogEuropean Journal of Pharmacology, 1969
- A method for the study of mechanisms of drug disposition in smooth muscleCanadian Journal of Physiology and Pharmacology, 1968
- THE UPTAKE OF CATECHOL AMINES AT HIGH PERFUSION CONCENTRATIONS IN THE RAT ISOLATED HEART: A NOVEL CATECHOL AMINE UPTAKE PROCESSBritish Journal of Pharmacology and Chemotherapy, 1965
- EFFECT OF COCAINE AND RELATED DRUGS ON THE UPTAKE OF NORADRENALINE BY HEART AND SPLEENBritish Journal of Pharmacology and Chemotherapy, 1961
- Effect of Cocaine on the Disposition of Noradrenaline labelled with TritiumNature, 1960